GlobeNewswire 21/11/2025 American Kidney Fund Hosts Third Patient Access Initiative Summit to Address Barriers to Kidney Care...
GlobeNewswire 19/11/2025 EYLEA HD® (aflibercept) Injection 8 mg Approved by FDA for the Treatment of Macular Edema Following ...
GlobeNewswire 19/11/2025 Libtayo® (cemiplimab) Approved in the European Union as First and Only Immunotherapy for Adjuvant Tr...
GlobeNewswire 17/11/2025 FDA Grants Fast Track Designation to Dewpoint Therapeutics’ DPTX3186 for the Treatment of Gastric Ca...
TeleTrader 15/11/2025 WEEKLY RECAP: US shutdown ends, BBC lawsuit, earnings
TeleTrader 14/11/2025 Europe closes lower on inflation data, UK yield spike
GlobeNewswire 13/11/2025 UPDATE Headwall Appoints Tim Spang as Chief Executive Officer
GlobeNewswire 13/11/2025 Headwall Appoints Tim Spang as Chief Executive Officer
GlobeNewswire 13/11/2025 Regeneron Highlights Progress at American Society of Hematology (ASH), with Updated Data in Multiple...
GlobeNewswire 13/11/2025 JD.com Announces Third Quarter 2025 Results
GlobeNewswire 12/11/2025 Alvotech Reports Results for the First Nine Months of 2025 and Provides a Business Update
TeleTrader 12/11/2025 Europe closes higher after earnings, data
TeleTrader 12/11/2025 Europe opens higher with data, earnings in focus
TeleTrader 12/11/2025 Europe set to open higher amid data, earnings
TeleTrader 12/11/2025 Bayer's Q3 sales down by 3.1% to €9.7 billion
GlobeNewswire 12/11/2025 PyroGenesis Announces Third Quarter 2025 Results
TeleTrader 11/11/2025 Europe closes higher with US govt shutdown end in sight
GlobeNewswire 10/11/2025 Dyadic Applied BioSolutions Expands Genetic Engineering Capabilities Through CRISPR/Cas9 Commercial ...
TeleTrader 10/11/2025 EARNINGS PREVIEW: Focus on Disney, Asian giants
GlobeNewswire 10/11/2025 UK High Court Rules in Favor of Alvotech Paving Way for Manufacture and Market Entry of AVT06, biosi...
GlobeNewswire 08/11/2025 Phase 2 Trials Demonstrating Antithrombotic Effect of Two Novel Regeneron Factor XI Antibodies Prese...
GlobeNewswire 08/11/2025 How modeling scenarios informed the emergence of a global carbon market coalition at COP30
GlobeNewswire 07/11/2025 Dupixent® (dupilumab) Pivotal Trial Met All Primary and Secondary Endpoints, Reducing Signs and Symp...
GlobeNewswire 07/11/2025 Press Release: ACAAI: Sanofi and Regeneron’s Dupixent pivotal study met all primary and secondary e...
GlobeNewswire 06/11/2025 Relay Therapeutics Reports Third Quarter 2025 Financial Results and Corporate Updates